U.S., Oct. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07885761) titled 'REVIVE-FR Registry' on Oct. 13.
Brief Summary: This registry aims to investigate treatment options for patients whose previously implanted biological aortic heart valve no longer functions properly. As patients with severe aortic stenosis are increasingly younger and at lower surgical risk, more patients may experience bioprosthetic valve failure during their lifetime.
Treatment options include implanting a new valve inside the existing valve using a catheter-based procedure, surgically removing the failed valve, or providing conservative medical treatment. The study will evaluate outcomes associated with these different treatment ...